Creon

New Zealand - English - Medsafe (Medicines Safety Authority)

Buy It Now

Active ingredient:
Pancreatin 300 mg (9,000U amylase/8000U lipase/210U total protease)
Available from:
Boehringer Ingelheim (NZ) Ltd
INN (International Name):
Pancreatin 300 mg (9,000U amylase/8000U lipase/210U total protease)
Dosage:
300 mg
Pharmaceutical form:
Modified release capsule
Composition:
Active: Pancreatin 300 mg (9,000U amylase/8000U lipase/210U total protease) Excipient: Dibutyl phthalate Dimeticone Gelatin   Hypromellose phthalate Iron oxide black Iron oxide red Iron oxide yellow   Light liquid paraffin Macrogol 4000 Titanium dioxide
Units in package:
Blister pack,
Class:
General sale
Prescription type:
General sale
Manufactured by:
Abbott Laboratories GmbH
Product summary:
Package - Contents - Shelf Life: Blister pack, -   - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, - 100 capsules - 24 months from date of manufacture stored at or below 25°C
Authorization number:
TT50-4663
Authorization date:
1990-02-22

Similar products

Search alerts related to this product

Share this information